Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 3-indolylmethylglucosinolate
2. Glucobrassicin
3. Indol-3-ylmethyl Glucosinolate
1. Glucobrassicin
2. Indolylmethylglucosinolate
3. 3-indolylmethylglucosinolate
4. Ea6eh0iu89
5. 4356-52-9
6. 3-img
7. Indolylmethyl Glucosinolate
8. Glucobrassicine
9. [(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1z)-2-(1h-indol-3-yl)-n-sulfooxyethanimidothioate
10. Indol-3-ylmethylglucosinolate
11. Unii-ea6eh0iu89
12. 3-indoleglucobrassicin
13. 1-s-[2-(1h-indol-3-yl)-n-(sulfooxy)ethanimidoyl]-1-thio-beta-d-glucopyranose
14. Q27109856
15. Beta-d-glucopyranose, 1-thio-, 1-(n-(sulfooxy)-1h-indole-3-ethanimidate)
16. .beta.-d-glucopyranose, 1-thio-, 1-(n-(sulfooxy)-1h-indole-3-ethanimidate), Z-
17. Glucopyranose, 1-thio-, 1-indole-3-acetohydroximate No-(hydrogen Sulfate), .beta.-d-
| Molecular Weight | 448.5 g/mol |
|---|---|
| Molecular Formula | C16H20N2O9S2 |
| XLogP3 | -0.1 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 7 |
| Exact Mass | 448.06102257 g/mol |
| Monoisotopic Mass | 448.06102257 g/mol |
| Topological Polar Surface Area | 216 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 686 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
51
PharmaCompass offers a list of Glucobrassicin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Glucobrassicin manufacturer or Glucobrassicin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Glucobrassicin manufacturer or Glucobrassicin supplier.
PharmaCompass also assists you with knowing the Glucobrassicin API Price utilized in the formulation of products. Glucobrassicin API Price is not always fixed or binding as the Glucobrassicin Price is obtained through a variety of data sources. The Glucobrassicin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Glucobrassicin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Glucobrassicin, including repackagers and relabelers. The FDA regulates Glucobrassicin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Glucobrassicin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Glucobrassicin supplier is an individual or a company that provides Glucobrassicin active pharmaceutical ingredient (API) or Glucobrassicin finished formulations upon request. The Glucobrassicin suppliers may include Glucobrassicin API manufacturers, exporters, distributors and traders.
Glucobrassicin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Glucobrassicin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Glucobrassicin GMP manufacturer or Glucobrassicin GMP API supplier for your needs.
A Glucobrassicin CoA (Certificate of Analysis) is a formal document that attests to Glucobrassicin's compliance with Glucobrassicin specifications and serves as a tool for batch-level quality control.
Glucobrassicin CoA mostly includes findings from lab analyses of a specific batch. For each Glucobrassicin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Glucobrassicin may be tested according to a variety of international standards, such as European Pharmacopoeia (Glucobrassicin EP), Glucobrassicin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Glucobrassicin USP).
